Back

Strengthening Cooperation Between Saidal and Abbott to Develop the Influenza Vaccine and Pharmaceutical Innovation

May 13, 2026اقتصاد – الشروق أونلاينechoroukonline.com
Strengthening Cooperation Between Saidal and Abbott to Develop the Influenza Vaccine and Pharmaceutical Innovation

Saidal and Abbott confirmed their commitment to enhancing joint cooperation in the pharmaceutical industry, particularly regarding the influenza vaccine 'Influvac', contributing to the development of the pharmaceutical sector and providing innovative health solutions for citizens. This came during the reception of the General Director of Saidal Group, Professor Mourad Belkhlef, for the Chargé d'Affaires at the U.S. Embassy in Algeria, Mark A. Shapiro, yesterday Tuesday accompanied by a delegation from the American company Abbott, at the production site 'Constantine 1' belonging to the group.

Share on social media

Related Articles

Mr. Rakash presents investment opportunities in Algeria to the national community in Switzerland

Mr. Rakash presents investment opportunities in Algeria to the national community in Switzerland

Algeria - The Director General of the Algerian Investment Promotion Agency, Omar Rakash, presented in Geneva (Switzerland) the investment opportunities offered by the Algerian economy during an information day dedicated to introducing the business climate in Algeria and attracting investors from the national community residing in Switzerland, as stated today, Wednesday, in a statement from the agency.

Nov 11, 2026aps.dz

News Disclaimer: Articles are curated from third-party sources for informational purposes. We do not verify or endorse the accuracy of third-party content.